Friday May 12, 10:07 am ET
NovaVision Vision Restoration Therapy, the First and Only Therapy to Improve Visual Field Deficit from Stroke or TBI, Recognized for Advancements in Healthcare Nationwide
BOCA RATON, Fla.–(BUSINESS WIRE)–May 12, 2006–NovaVision, Inc. today announced it received the Palm Beach County Medical Society Advancements in Healthcare Award at the organization’s 3rd annual Heroes in Medicine Award Program.
NovaVision was one of 31 individuals and groups nominated for their contributions to improving medical care and programs globally, nationally and locally. The award was presented during a luncheon at the Ritz Carlton in Manalapan on April 28; proceeds from the event supported Project Access, a community-based program to increase access to healthcare for the uninsured.
NovaVision was recognized for its success expanding patient access to NovaVision VRT(TM) Vision Restoration Therapy(TM) (VRT), a noninvasive medical device that improves visual field deficits caused by stroke or traumatic brain injury (TBI)–a condition previously considered untreatable. In the three years since VRT was cleared for marketing in the United States by the FDA, NovaVision has collaborated with leading medical institutions across the country to create 30 Partner Clinics that offer the therapy–five in Florida.
“Receiving this honor from the Palm Beach County Medical Society is a testament to the hard work and dedication of NovaVision’s employees and the talented neurologists, neuro-ophthalmologists, ophthalmologists, therapists and technicians who administer VRT in South Florida and across the country,” Navroze Mehta, president and CEO of NovaVision, said. “NovaVision is proud of the work it has done to improve the quality of life for more than one thousand stroke and TBI patients, but there is more to be done. Our team is dedicated to expanding patient access to the therapy and introducing new innovations to improve the VRT diagnostic and therapy medical devices.”
To date, more than 1,000 patients have been treated with VRT and clinical results are positive. Data from a recent retrospective study show 70 percent of patients who underwent VRT for the initial six-month treatment period showed clinically meaningful improvements in their vision.
The need for a rehabilitative therapy like VRT is substantial. An estimated 4.8 million people have survived a stroke (American Heart Association, 2004 Update), and at least 5.3 million Americans currently live with disabilities resulting from TBI (Centers for Disease Control and Prevention, May 2004). Approximately 1.5 million stroke and TBI patients in the United States suffer from major visual field deficits, and that number grows by more than 90,000 new patients each year.
About NovaVision, Inc.
NovaVision VRT(TM) Vision Restoration Therapy(TM) (VRT) is based on groundbreaking research in neuroplasticity. VRT is an FDA-cleared, patented, non-invasive medical device that may restore vision in stroke and traumatic brain injury (TBI) patients with visual deficits. While speech, physical and occupational therapy are the long-standing, mainstream treatment regimens for stroke and TBI patients, VRT is the first FDA-cleared clinical application of rehabilitation for vision loss. NovaVision, Inc. develops and distributes VRT.
NovaVision, Inc. is headquartered in Boca Raton, Florida with European offices that include clinics and research and development in Magdeburg, Germany. VRT is based on 15 years of research with clinical studies published in leading journals including Nature Medicine, Neurology, and The Journal of Cognitive Neuroscience. Data from a recent retrospective study identified that more than 70 percent of patients who underwent VRT for an initial six-month treatment period showed clinically meaningful improvements in their vision. VRT is currently offered at 30 leading medical institutions and private practices nationwide including the Neurological Institute of New York at Columbia University Medical Center, the Department of Neurology University of Miami, Emory Healthcare Eye Center, the Rusk Institute of Rehabilitation Medicine at NYU Medical Center, Johns Hopkins University Wilmer Eye Institute, HealthSouth Sunrise Rehabilitation Hospital, HealthSouth Scottsdale Rehabilitation Hospital, Doheny Eye Institute at USC, and others. For more information and a complete list of NovaVision VRT clinics please visit www.novavision.com or call 888.205.0800.